Financhill
Buy
59

CORT Quote, Financials, Valuation and Earnings

Last price:
$57.57
Seasonality move :
7.81%
Day range:
$57.02 - $59.72
52-week range:
$20.84 - $75.00
Dividend yield:
0%
P/E ratio:
46.44x
P/S ratio:
9.69x
P/B ratio:
8.94x
Volume:
882.5K
Avg. volume:
1.1M
1-year change:
135.93%
Market cap:
$6.1B
Revenue:
$675M
EPS (TTM):
$1.24

Earnings Data

Next earnings date for CORT
May 01
2025
Most recent earnings per share
$0.26
Missed by $0.16
(Feb 26/2025)
Consensus Estimate
$0.42
(Feb 26/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CORT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/01/2025 Q1 $177.9M -- -- $0.15 --
02/26/2025 Q4 $200.1M $181.9M $0.26 $0.42 -$0.16
10/30/2024 Q3 $172M $182.5M $0.41 $0.29 $0.12
07/29/2024 Q2 $155.2M $163.8M $0.32 $0.24 $0.08
05/01/2024 Q1 $141.2M $146.8M $0.25 $0.22 $0.03
02/15/2024 Q4 $129.3M $135.4M $0.28 $0.26 $0.03
11/01/2023 Q3 -- -- $0.28 $0.23 $0.05
08/02/2023 Q2 -- -- $0.25 $0.15 $0.10
05/03/2023 Q1 -- -- $0.14 $0.21 -$0.07
02/28/2023 Q4 -- -- $0.14 $0.28 -$0.14
11/03/2022 Q3 -- -- $0.30 $0.28 $0.02
08/03/2022 Q2 -- -- $0.24 $0.28 -$0.04
05/05/2022 Q1 -- -- $0.20 $0.31 -$0.11
02/15/2022 Q4 -- -- $0.26 $0.35 -$0.09
11/03/2021 Q3 -- -- $0.24 -- --
07/29/2021 Q2 -- -- $0.21 $0.17 $0.05
05/06/2021 Q1 -- -- $0.18 $0.19 -$0.01
02/08/2021 Q4 -- -- $0.20 $0.17 $0.03
11/03/2020 Q3 -- -- $0.17 $0.23 -$0.06
08/04/2020 Q2 -- -- $0.23 $0.21 $0.02
05/04/2020 Q1 -- -- $0.25 $0.21 $0.04
02/20/2020 Q4 -- -- $0.24 $0.26 -$0.02
11/07/2019 Q3 -- -- $0.22 $0.21 $0.01
08/01/2019 Q2 -- -- $0.25 $0.19 $0.06
05/09/2019 Q1 -- -- $0.20 $0.18 $0.02
02/25/2019 Q4 -- -- $0.24 $0.21 $0.03
11/01/2018 Q3 -- -- $0.22 $0.21 $0.01
08/09/2018 Q2 -- -- $0.20 $0.24 -$0.04
05/08/2018 Q1 -- -- $0.19 $0.18 $0.02
02/22/2018 Q4 -- -- -- -- --
11/02/2017 Q3 -- -- $0.14 $0.14 --
05/01/2017 Q1 -- -- -- $0.03 --
01/30/2017 Q4 -- -- -- $0.05 --
11/01/2016 Q3 -- -- $0.02 $0.01 $0.01
08/03/2016 Q2 -- -- $0.02 $0.01 $0.01
05/03/2016 Q1 -- -- $0.01 $0.01 --
11/05/2015 Q3 -- -- -- -- --
08/05/2015 Q2 -- -- -- -- --
05/07/2015 Q1 -- -- -- -- --

Corcept Therapeutics Earnings Questions

  • How Much did Corcept Therapeutics Generate in Revenue Last Quarter?

    Corcept Therapeutics reported $181.9M worth of top line sales in its most recent quarter.

  • Did Corcept Therapeutics Beat Earnings Last Quarter?

    Corcept Therapeutics announced earnings per share of $0.26 which represents a miss of analyst forecast a $0.42 per share.

  • Is Corcept Therapeutics Profitable?

    Corcept Therapeutics reported $178.9M that represents $1.50 per share over the last quarter.

  • What is the Analyst Consensus for Corcept Therapeutics EPS Next Year?

    Corcept Therapeutics's earnings are forecast to grow from $1.23 per share to $1.41 per share next year representing an increase of 55.29%.

  • When is Corcept Therapeutics's Earnings Date?

    Corcept Therapeutics's next earnings date is May 1, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Roblox Stock a Buy, Sell or Hold?
Is Roblox Stock a Buy, Sell or Hold?

Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
50
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
82
EXOD alert for Mar 21

Exodus Movement [EXOD] is up 17.89% over the past day.

Buy
69
SIG alert for Mar 20

Signet Jewelers [SIG] is down 0.64% over the past day.

Sell
36
HQY alert for Mar 20

HealthEquity [HQY] is up 0.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock